Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals | 6 | 0 | 1 | 0 | €13.20 | €21.53 | 63.100% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €130.05 | €147.62 | 13.507% |
| Cocrystal Pharma Inc. | 6 | 0 | 1 | 0 | €1.39 | €10.08 | 625.036% |
| Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
| Universal Health Services B | 9 | 3 | 2 | 1 | €154.00 | €159.70 | 3.704% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
| Glycomimetics Inc. | 5 | 0 | 1 | 0 | €1.60 | €7.35 | 360.050% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €28.40 | €32.49 | 14.417% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Personalis Inc | 5 | 0 | 1 | 0 | €1.16 | €3.23 | 178.105% |
| Akebia Therapeutics Inc. | 8 | 3 | 2 | 1 | €1.25 | €3.60 | 187.698% |
| Bausch Health Companies Inc. | 4 | 0 | 2 | 0 | €8.04 | €13.00 | 61.712% |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.18 | €5.00 | 19.617% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Atossa Genetics Inc | 5 | 1 | 2 | 0 | €1.41 | €3.72 | 164.091% |
| Chemed Corp. | 4 | 0 | 0 | 0 | €565.00 | €588.14 | 4.096% |
| Fresenius SE & Co. KGaA | 4 | 0 | 2 | 0 | €27.18 | - | - |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.26 | €8.50 | 35.783% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €23.60 | €29.29 | 24.122% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.52 | €99.50 | 8.719% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €288.40 | - | - |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.62 | €70.00 | 56.880% |
| X4 Pharmaceuticals, Inc. | 4 | 0 | 1 | 0 | €1.15 | €2.76 | 140.629% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.00 | €26.58 | 10.756% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |